TCL Archive In Brief: FCRC Committee Loses Chance To influence RFP; Recompetition To Remain On Schedule November 5, 1976
TCL Archive Upton Considers Moving Basic Research Contracts To grants; Staff Changes Possible, Newell Stay July 22, 1977
TCL Archive ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies June 5, 2009
TCL Archive FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer April 29, 1988
